Viewing Study NCT00358566


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2025-12-25 @ 8:40 PM
Study NCT ID: NCT00358566
Status: TERMINATED
Last Update Posted: 2008-05-19
First Post: 2006-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Sponsor: Pharmexa A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module